Papers

2

Total Citations

75

H-Index

2

About

John Braisted is a pioneering researcher at the intersection of stem cell biology and automation, whose work is revolutionizing the scalable manufacturing of human induced pluripotent stem cells (hiPSCs). His primary research focuses on developing robotic, high-throughput biomanufacturing platforms to overcome the critical bottlenecks in translating stem cell therapies from the lab to the clinic. Braisted’s major contribution lies in demonstrating that fully automated systems can efficiently handle the complex processes of hiPSC self-renewal and functional differentiation, replacing highly variable and labor-intensive manual culture methods. His landmark 2021 paper, "Robotic high-throughput biomanufacturing and functional differentiation of human pluripotent stem cells," has already garnered 68 citations, underscoring its significance in the field. This work, along with a foundational 2020 study, provides a robust framework for producing consistent, high-quality cells at scale—a key step toward making regenerative medicine a practical reality. By solving the challenge of reproducibility in stem cell manufacturing, Braisted is enabling high-throughput drug screening, disease modeling, and cell therapy development, positioning him as a leader in the future of automated biomanufacturing.

Research Focus

Key Achievements

2
H-Index
2
Papers
75
Total Citations
38
Avg Citations/Paper
🏆 Most Cited Paper
Robotic high-throughput biomanufacturing and functional differentiation of human pluripotent stem cells
68 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: National Center for Advancing Translational Sciences, National Institutes of Health

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago